Skip to main content

ADVERTISEMENT

Rochelle Nataloni, Contributing Editor

Research in Review
11/01/2017
Rochelle Nataloni, Contributing Editor
These programs combine individual patient visits with a group hands-on experience, education, and peer support. 
These programs combine individual patient visits with a group hands-on experience, education, and peer support. 
These programs combine...
11/01/2017
The Dermatologist
Research in Review
10/27/2017
Rochelle Nataloni, Contributing Editor
Dr Beck discusses her research characterizing the epithelial tight junction defects at the molecular level in atopic dermatitis and the future of eczema treatment.
Dr Beck discusses her research characterizing the epithelial tight junction defects at the molecular level in atopic dermatitis and the future of eczema treatment.
Dr Beck discusses her research...
10/27/2017
The Dermatologist
08/30/2017
Rochelle Nataloni, Contributing Editor
Yolanda R. Helfrich, MD, discusses exciting developments in rosacea research, as well as what inspired her to specialize in the field.
Yolanda R. Helfrich, MD, discusses exciting developments in rosacea research, as well as what inspired her to specialize in the field.
Yolanda R. Helfrich, MD,...
08/30/2017
The Dermatologist
Research in Review
08/09/2017
Rochelle Nataloni, Contributing Editor
Kaiser Permanente researcher and clinician has studied how inflammatory effects of psoriasis can impact the entire body.
Kaiser Permanente researcher and clinician has studied how inflammatory effects of psoriasis can impact the entire body.
Kaiser Permanente researcher and...
08/09/2017
The Dermatologist
Research in Review
07/26/2017
Rochelle Nataloni, Contributing Editor
Eric Simpson, MD, discusses the burden of disease, disease prevention, and novel therapies.
Eric Simpson, MD, discusses the burden of disease, disease prevention, and novel therapies.
Eric Simpson, MD, discusses the...
07/26/2017
The Dermatologist
Research in Review
06/22/2017
Rochelle Nataloni, Contributing Editor
Robert Sidbury, MD, MPH, talks about new eczema medications, his research, and the importance of primary care providers understanding how impactful AD can be.  
Robert Sidbury, MD, MPH, talks about new eczema medications, his research, and the importance of primary care providers understanding how impactful AD can be.  
Robert Sidbury, MD, MPH, talks...
06/22/2017
The Dermatologist
Research in Review
05/24/2017
Rochelle Nataloni, Contributing Editor
Gil Yosipovitch, MD, reflects on the strides being made in the world of eczema and atopic dermatitis, his work on itch as a complex disease, and future plans that look at the effect of itch by targeting pathways in the brain.
Gil Yosipovitch, MD, reflects on the strides being made in the world of eczema and atopic dermatitis, his work on itch as a complex disease, and future plans that look at the effect of itch by targeting pathways in the brain.
Gil Yosipovitch, MD, reflects on...
05/24/2017
The Dermatologist
03/03/2017
Rochelle Nataloni, Contributing Editor
Dr Gelfand discusses the evolving landscape of psoriasis research and a multidisciplinary perspective to treating patients who present with inflammatory conditions in multiple organ systems.
Dr Gelfand discusses the evolving landscape of psoriasis research and a multidisciplinary perspective to treating patients who present with inflammatory conditions in multiple organ systems.
Dr Gelfand discusses the...
03/03/2017
The Dermatologist
Research in Review
01/31/2017
Rochelle Nataloni, Contributing Editor
Alice Gottlieb, MD, PhD, discusses a range of topics on psoriasis including her past and current research and future outlook of the disease state.  
Alice Gottlieb, MD, PhD, discusses a range of topics on psoriasis including her past and current research and future outlook of the disease state.  
Alice Gottlieb, MD, PhD,...
01/31/2017
The Dermatologist
Feature Story
11/01/2016
Rochelle Nataloni, Contributing Editor
Large dermatology practices and private equity firms are acquiring practices with increasing regularity. The impact of what it will mean for the specialty in the long run is not yet known.
Large dermatology practices and private equity firms are acquiring practices with increasing regularity. The impact of what it will mean for the specialty in the long run is not yet known.
Large dermatology practices and...
11/01/2016
The Dermatologist